HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDTIDE

20.660

-0.120-0.58%

Volume:70.80K

Turnover:1.46M

Market Cap:2.93B

PE:10.83

High:20.900

Open:20.580

Low:20.580

Close:20.780

52wk High:32.860

52wk Low:17.640

Shares:141.80M

HK Float Shares:141.80M

Volume Ratio:0.97

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.908

ROE:10.89%

ROA:6.82%

PB:1.53

PE(LYR):10.83

PS:4.54

Loading ...

Overview Company News Filings

MEDTIDE Logs Stable Share Capital and Full Public Float Compliance in September 2026 Return

Bulletin Express

Medtide Says Li Lingmei Resigns as Executive Director

Medtide Acquires China Land, Property for Peptide CDMO Project

MT Newswires Live

MEDTIDE Announces Executive Director Resignation

Medtide Inc. - Intends to Further Integrate Adjacent Land Parcel in Phase Ii to Develop Large-Scale CDMO Production Park, Others

THOMSON REUTERS

Medtide Inc. Interim 2026: Revenue Slips 7.6%, Profit Halves on Order Deferrals and FX Losses

Bulletin Express

Medtide - Li Lingmei Resigns as Executive Director Effective September 24, 2026

THOMSON REUTERS

Precision Peptide Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event

Precision Peptide Starts U.S. Testing of Thymosin Alpha-1 Transdermal Patch

Medtide (SEHK:3880) Stock Drifts As Margin Gains Meet Revenue Reset

Simply Wall St.

MEDTIDE Proposes Adoption of Restricted Share Unit Scheme

MEDTIDE Posts 47.4% Drop in Net Profit for Interim Results

Medtide Proposes Bylaw Changes to Allow Board Size Range of Five to Nine Directors

Medtide Proposes 10-Year RSU Incentive Scheme with 14,180,000-Share Mandate Limit

Medtide Hy Revenue Rmb234.5 Mln

THOMSON REUTERS

Medtide H1 FY26 Profit Drops 47.4% to RMB 53.68 Million; Revenue Falls 7.6% to RMB 234.52 Million

Precision Peptide Develops Needle-Free Tirzepatide Transdermal Patch in U.S

Medtide Schedules Board Meeting to Review Interim Results

Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?

Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/03880/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"MEDTIDE","latestPrice":20.66,"timestamp":1791446137821,"preClose":20.78,"halted":0,"volume":70800,"delay":0,"changeRate":-0.005774783445620837,"floatShares":141800000,"shares":141800000,"eps":1.9080290234982025,"marketStatus":"Not Yet Opened","change":-0.12,"latestTime":"10-08 15:55:37","open":20.58,"high":20.9,"low":20.58,"amount":1463176,"amplitude":0.015399,"askPrice":21.1,"askSize":100,"bidPrice":20.58,"bidSize":700,"shortable":0,"etf":0,"ttmEps":1.3940563390757685,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":0,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":20.78,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":0.974133,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"6.82%","roe":"10.89%","lyrEps":1.908029,"volumeRatio":0.974133,"shares":141800000,"dividePrice":0,"high":20.9,"amplitude":0.015399,"preClose":20.78,"low":20.58,"week52Low":17.64,"pbRate":"1.53","psRate":"4.54","week52High":32.86,"institutionHeld":0,"latestPrice":20.66,"committee":0.75,"eps":1.9080290234982025,"divideRate":0,"volume":70800,"delay":0,"ttmEps":1.3940563390757685,"open":20.58,"prevYearClose":30.48,"prevWeekClose":21.18,"prevMonthClose":21.52,"prevQuarterClose":21.52,"fiveDayClose":21.52,"twentyDayClose":19.95,"sixtyDayClose":24.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754409600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-10-07","current":14.820894,"percent":0.363057,"low":11.049775,"twenty":12.665822,"median":29.238878,"eighty":36.933375,"high":89.502411,"avg":31.215727,"sd":21.135814,"marketCap":2946604000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-27","current":25.407751,"twenty":30.961293,"median":35.900465,"eighty":70.436098,"marketCap":3181992000},{"date":"2026-04-02","current":12.694395,"twenty":30.374151,"median":35.877946,"eighty":69.313609,"marketCap":3139452000},{"date":"2026-04-10","current":12.836208,"twenty":29.799581,"median":35.844414,"eighty":69.013634,"marketCap":3199008000},{"date":"2026-04-17","current":12.660198,"twenty":28.991894,"median":35.202659,"eighty":68.828913,"marketCap":3156468000},{"date":"2026-04-24","current":12.397874,"twenty":27.75939,"median":35.115214,"eighty":68.535434,"marketCap":3091240000},{"date":"2026-04-30","current":12.269611,"twenty":26.785787,"median":34.99421,"eighty":68.377965,"marketCap":3060044000},{"date":"2026-05-08","current":12.363155,"twenty":25.983648,"median":34.594549,"eighty":67.965697,"marketCap":3094076000},{"date":"2026-05-15","current":12.534163,"twenty":25.665008,"median":34.175169,"eighty":67.389311,"marketCap":3145124000},{"date":"2026-05-22","current":12.642172,"twenty":25.399381,"median":33.645975,"eighty":67.311524,"marketCap":3164976000},{"date":"2026-05-29","current":12.270986,"twenty":25.218458,"median":33.406025,"eighty":67.131365,"marketCap":3082732000},{"date":"2026-06-05","current":11.125953,"twenty":24.642571,"median":33.30501,"eighty":64.550519,"marketCap":2799132000},{"date":"2026-06-12","current":13.017265,"twenty":13.007169,"median":33.187074,"eighty":42.637728,"marketCap":3272744000},{"date":"2026-06-18","current":12.671021,"twenty":12.943368,"median":33.126975,"eighty":41.844528,"marketCap":3193336000},{"date":"2026-06-26","current":12.518344,"twenty":12.901138,"median":33.023157,"eighty":41.133711,"marketCap":3139452000},{"date":"2026-07-03","current":12.429887,"twenty":12.724861,"median":32.858736,"eighty":40.911062,"marketCap":3119600000},{"date":"2026-07-10","current":13.463401,"twenty":12.685266,"median":32.845563,"eighty":39.914225,"marketCap":3374840000},{"date":"2026-07-17","current":13.021079,"twenty":12.724861,"median":32.687847,"eighty":39.039678,"marketCap":3275580000},{"date":"2026-07-24","current":12.950528,"twenty":12.774507,"median":32.49883,"eighty":38.697228,"marketCap":3258564000},{"date":"2026-07-31","current":12.667228,"twenty":12.718655,"median":32.350921,"eighty":38.507791,"marketCap":3193336000},{"date":"2026-08-07","current":11.576024,"twenty":12.668745,"median":32.105235,"eighty":38.341571,"marketCap":2923916000},{"date":"2026-08-14","current":12.133289,"twenty":12.639428,"median":31.958711,"eighty":38.254613,"marketCap":3068552000},{"date":"2026-08-21","current":13.057601,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"marketCap":3309612000},{"date":"2026-08-28","current":15.462922,"twenty":12.621641,"median":31.567575,"eighty":37.94638,"marketCap":3048700000},{"date":"2026-09-04","current":15.370447,"twenty":12.633554,"median":31.132408,"eighty":37.865542,"marketCap":3031684000},{"date":"2026-09-11","current":13.30358,"twenty":12.639428,"median":30.942991,"eighty":37.772667,"marketCap":2627554000},{"date":"2026-09-18","current":14.784774,"twenty":12.648608,"median":30.467091,"eighty":37.452165,"marketCap":2923916000},{"date":"2026-09-25","current":16.364708,"twenty":12.659036,"median":29.807701,"eighty":37.099262,"marketCap":3230204000},{"date":"2026-10-02","current":15.199274,"twenty":12.661604,"median":29.551051,"eighty":37.047606,"marketCap":3003324000},{"date":"2026-10-07","current":14.890961,"twenty":12.665822,"median":29.238878,"eighty":36.933375,"marketCap":2946604000}],"updateTime":1791463249625},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1190333194","title":"MEDTIDE Logs Stable Share Capital and Full Public Float Compliance in September 2026 Return","url":"https://stock-news.laohu8.com/highlight/detail?id=1190333194","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190333194?lang=en_us&edition=fundamental","pubTime":"2026-10-06 17:22","pubTimestamp":1791278542,"startTime":"0","endTime":"0","summary":"Medtide Inc. (MEDTIDE) has filed its monthly return for the period ended 30 September 2026, confirming that both authorised and issued share capital remained unchanged during the month. Total...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669946178","title":"Medtide Says Li Lingmei Resigns as Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2669946178","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669946178?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:20","pubTimestamp":1790245217,"startTime":"0","endTime":"0","summary":"BRIEF-Medtide Says Li Lingmei Resigns As Executive DirectorSept 24 (Reuters)-Medtide Inc.3880.HK:LI LINGMEI RESIGNS AS EXECUTIVE DIRECTOR EFFECTIVE SEPTEMBER 24, 2026Further company coverage:3880.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669687461","title":"Medtide Acquires China Land, Property for Peptide CDMO Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2669687461","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669687461?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:04","pubTimestamp":1790244246,"startTime":"0","endTime":"0","summary":"Medtide  completed the acquisition of a parcel of industrial land and property in Hangzhou City, China, a Thursday Hong Kong bourse filing said.The land and property are proposed to be used in phase I of the company's large-scale peptide and oligonucleotide CDMO production base project.The company plans to construct a large-scale peptide active pharmaceutical ingredients production line under the project with an estimated designed annual production capacity of 3 to 5 tonnes.Further expansion using an adjacent land parcel to develop a large-scale CDMO production park is also part of the company's plan.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JJJ.SI","SRT.SI","CDMO","03880","BK4139","BK1141","CLR.SI","CFA.SI","SRU.SI","GLS.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194254391","title":"MEDTIDE Announces Executive Director Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=1194254391","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194254391?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:50","pubTimestamp":1790239813,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has issued an announcement stating that Ms. Li Lingmei has resigned from her position as an executive director due to personal work arrangements, effective September 24, 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669637184","title":"Medtide Inc. - Intends to Further Integrate Adjacent Land Parcel in Phase Ii to Develop Large-Scale CDMO Production Park, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2669637184","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669637184?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:48","pubTimestamp":1790239734,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182821218","title":"Medtide Inc. Interim 2026: Revenue Slips 7.6%, Profit Halves on Order Deferrals and FX Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1182821218","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182821218?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:47","pubTimestamp":1790239669,"startTime":"0","endTime":"0","summary":"Medtide Inc. released its 2026 interim results, reporting revenue of RMB 234.52 million, a 7.6% year-on-year decline caused largely by delayed deliveries that shifted portions of customer orders into...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medtide Inc. Interim 2026: Revenue Slips 7.6%, Profit Halves on Order Deferrals and FX Losses","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463441","title":"Medtide - Li Lingmei Resigns as Executive Director Effective September 24, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463441?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:44","pubTimestamp":1790239455,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0JM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669314618","title":"Precision Peptide Becomes Strategic Sponsor of Championing Mental Health 3 Boxing Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2669314618","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669314618?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:03","pubTimestamp":1790075004,"startTime":"0","endTime":"0","summary":"Precision Peptide becomes strategic sponsor of Championing Mental Health 3 boxing eventThe Precision Peptide Company will sponsor Championing Mental Health 3 boxing event on Sept. 26, 2026 in Commerce","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3TrmWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322134","title":"Precision Peptide Starts U.S. Testing of Thymosin Alpha-1 Transdermal Patch","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322134?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:04","pubTimestamp":1788865487,"startTime":"0","endTime":"0","summary":"Precision Peptide starts U.S. testing of Thymosin Alpha-1 transdermal patchThe Precision Peptide Company started formal U.S. testing of a Thymosin Alpha-1 transdermal patch, targeting completion in Q3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc8w6w6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662095636","title":"Medtide (SEHK:3880) Stock Drifts As Margin Gains Meet Revenue Reset","url":"https://stock-news.laohu8.com/highlight/detail?id=2662095636","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662095636?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:33","pubTimestamp":1787916832,"startTime":"0","endTime":"0","summary":"Medtide shares have drifted lower over the past week and month, yet the latest half year earnings land with a very different message. The headline is margin power. Net profit margin over the last 12 months is 30.7%, compared with 22.2% a year earlier, while earnings per share on that same basis sit at 1.19 CNY. The stock closed at HK$21.5 on a trailing P/E of 15.5x, which leaves today’s muted price reaction at odds with the profitability story Medtide just put on the table.\nLove Medtide’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-stock-drifts-as-margin-gains-meet-revenue-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3880/medtide-shares/news/medtide-sehk3880-stock-drifts-as-margin-gains-meet-revenue-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","JOYT","BK1141","DECU","03880","GXDW","PMDE","FEBU","RGLO","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158944843","title":"MEDTIDE Proposes Adoption of Restricted Share Unit Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1158944843","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158944843?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:52","pubTimestamp":1787820762,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) announced that on August 27, 2026, its board of directors passed resolutions concerning the proposed adoption of a restricted share unit scheme and the proposed adoption of a service...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128983823","title":"MEDTIDE Posts 47.4% Drop in Net Profit for Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1128983823","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128983823?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:41","pubTimestamp":1787820096,"startTime":"0","endTime":"0","summary":"MEDTIDE (03880) has released its interim results for 2026, reporting revenue of approximately RMB 235 million, a year-on-year decrease of 7.6%. Gross profit stood at around RMB 136 million, down...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774375","title":"Medtide Proposes Bylaw Changes to Allow Board Size Range of Five to Nine Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774375?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:40","pubTimestamp":1787820000,"startTime":"0","endTime":"0","summary":"Medtide proposes bylaw changes to allow board size range of five to nine directorsMedtide unveiled bylaw changes covering its Articles of Association plus board and shareholder-meeting procedure rules","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2FjHyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748347","title":"Medtide Proposes 10-Year RSU Incentive Scheme with 14,180,000-Share Mandate Limit","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662748347?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:35","pubTimestamp":1787819708,"startTime":"0","endTime":"0","summary":"Medtide proposes 10-year RSU incentive scheme with 14,180,000-share mandate limitMedtide set plans to adopt a 2026 RSU Scheme, subject to shareholder approval at an extraordinary general meeting.Schem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL5TZL4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662747771","title":"Medtide Hy Revenue Rmb234.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662747771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662747771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:32","pubTimestamp":1787819534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXL0Q8SQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771718","title":"Medtide H1 FY26 Profit Drops 47.4% to RMB 53.68 Million; Revenue Falls 7.6% to RMB 234.52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771718","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771718?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:31","pubTimestamp":1787819477,"startTime":"0","endTime":"0","summary":"Medtide H1 FY26 profit drops 47.4% to RMB 53.68 million; revenue falls 7.6% to RMB 234.52 millionMedtide posted IFRS profit attributable to owners of the parent of RMB 53.68 million, down 47.4% year o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2y4PHw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473224","title":"Precision Peptide Develops Needle-Free Tirzepatide Transdermal Patch in U.S","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473224","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473224?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137449,"startTime":"0","endTime":"0","summary":"Precision Peptide develops needle-free tirzepatide transdermal patch in U.SThe Precision Peptide Company is developing a needle-free tirzepatide transdermal patch in the U.S. as an expansion of its de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4zwmm5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660124483","title":"Medtide Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660124483","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660124483?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:34","pubTimestamp":1786955640,"startTime":"0","endTime":"0","summary":"Medtide schedules board meeting to review interim resultsMedtide will hold a board meeting on Aug. 27, 2026 to consider interim results for the six months ended June 30, 2026.Disclaimer:This news brie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL6Gc7j2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119829447","title":"Hong Kong Stock CXO Sector Rallies; Will MEDTIDE (03880) Defy the Trend or Bounce Back After Its Profit Warning?","url":"https://stock-news.laohu8.com/highlight/detail?id=1119829447","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119829447?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:26","pubTimestamp":1786069600,"startTime":"0","endTime":"0","summary":" On July 31, after the market close, MEDTIDE (03880) issued a profit warning for its 26H1 fiscal year. The company expects period revenue of approximately RMB 229.8-239.2 million, a year-over-year...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","NIFE","BK4588","BK1141","WX","CXO","VXUS","03880","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657544565","title":"Cpc Scientific Announces U.S. FDA Pre-License Inspection (Pli) Successfully Completed at Its Hangzhou Cgmp Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent Bla Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2657544565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657544565?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:11","pubTimestamp":1785931860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA7VZCWP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}]}}